MP
MapLight Therapeutics, Inc. (MPLT)
NASDAQ·Healthcare·Biotechnology
$11.07
+1.56%
Mkt Cap $483.77M
Analyst Ratings
Buy
10
Hold
2
Sell
0
Price Target (22 analysts)
$29.40
Range $13.00 – $46.00
Implied Upside
+165.6%
Consensus $29.40 vs current $11.07